Coral Laboratories Limited (CORALAB) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE683E01017
Key metrics
- Market Cap
- ₹230 Cr
- P/E Ratio
- 11.97
- EPS
- 53.74
- Book Value
- 585.33
- P/B Ratio
- 1.1
- ROE
- 7.83%
- ROCE
- 6.13%
- Debt / Equity
- 0.02
- Net Margin
- 19.07%
- Revenue Growth
- -25.31%
- Profit Growth
- -32.18%
- Dividend Yield
- 0.31%
- 52W High
- ₹679.00
- 52W Low
- ₹360.00
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Coral Laboratories Limited
Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally. The company offers non-sterile products, including antibiotics/antibacterial, antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic, antimalarial drugs, antipsychotic drugs, and thyroid products; topical, oral antiseptic, and calcium preparations; mouthwashes; nutritional, protein, and iron supplements; kits; appetizers; and other products. It also provides sterile products, such as small volume liquid, cephalosporin, betalactam, and lyophilized injectables; eye, ear, and nose drops; nasal sprays and metered dose inhalers; and large volume parenteral. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 80.03%
The full Coral Laboratories Limited analysis
Create a free account to open the complete CORALAB deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.